TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. Show more

951 Yamato Road, Boca Raton, FL, 33431, United States

Drug Manufacturers - Specialty & Generic

Healthcare

Market Cap

23.61M

52 Wk Range

$0.98 - $2.95

Previous Close

$2.04

Open

$2.06

Volume

10,068

Day Range

$2.03 - $2.08

Enterprise Value

21.26M

Cash

8.419M

Avg Qtr Burn

N/A

Insider Ownership

7.45%

Institutional Own.

33.97%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
TX-004HR: IMVEXXY™ (estradiol vaginal inserts) Details Dyspareunia (Moderate to Severe)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) Details Birth Control (Contraception)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TX-001HR: BIJUVA™ (Estradiol and Progesterone) Details Moderate to Severe Vasomotor Symptoms Due to Menopause	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.